IsoPSA test for prostate cancer

[madman]

Diagnostics company opens new facility to scale up production of IsoPSA test for prostate cancer

The new space includes a clinical laboratory for IsoPSA testing, labs for research and development, offices, and manufacturing spaces for production and distribution of in vitro diagnostic kits.

www.urologytimes.com

The non-invasive IsoPSA blood test assesses high-grade prostate cancer likelihood before or after a biopsy. Recently included in National Comprehensive Cancer Network guidelines for early detection. A real-world study on 734 patients aged 50+ with PSA levels between 4-100 ng/mL and no history of prostate cancer showed a 55% reduction in biopsy recommendations and a 9% reduction in MRI imaging with IsoPSA. High concordance between physician recommendations and IsoPSA results. IsoPSA has FDA Breakthrough Therapy designation and awaits FDA premarket approval.

 

[madman]

TRT and the Prostate

Testosterone Treatment and the Risk of Prostate Adverse Events (2022) Jason A. Levy, DO, MS, Arthur L. Burnett, MD, MBA, Adrian S. Dobs, MD, MHS INTRODUCTION Definition Hypogonadism is a clinical syndrome that results from failure of the testis to produce physiologic concentrations of...

www.excelmale.com